Silicone adhesive, a better matrix for tolterodine patchesa research based on in vitro/in vivo studies

Drug Development and Industrial Pharmacy

Volumn 38, Issue 8, 2012, Pages 1008-1014

  Liu, Jie ^a   Wang, Zhongyan ^a   Liu, Chao ^a   Xi, Honglei ^a   Li, Chunmei ^a   Chen, Yang ^a   Sun, Lin ^a   Mu, Liwei ^a   Fang, Liang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Acrylic adhesive; in vitro studies; in vivo studies; Silicone adhesive; Tolterodine; Transdermal patch

Indexed keywords

ACRYLIC ACID; ADHESIVE AGENT; SILICONE; TOLTERODINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; MALE; NONHUMAN; PREDICTION; RABBIT; TRANSDERMAL PATCH;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; BENZHYDRYL COMPOUNDS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CRESOLS; DRUG DELIVERY SYSTEMS; MALE; MYRISTATES; PHENYLPROPANOLAMINE; RABBITS; SILICONES; SKIN; SKIN ABSORPTION; TRANSDERMAL PATCH; URINARY BLADDER, OVERACTIVE;

EID: 84863456080     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.637049     Document Type: Article

References (20)

1. Nilvebrant L, Glas G, Jonsson Å, Sparf B. (1994). The in vitro pharmacological profle of tolterodine-new agent for the treatment of urinary urge incontinence. Neurourol Urodyn, 13:433-435.
2. Abrams P, Cardozo L, Fall M, Grifths D, Rosier P, Ulmsten U et al.; Standardisation Sub-committee of the International Continence Society. (2002). The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn, 21:167-178.
3. Nilvebrant L, Hallén B, Larsson G. (1997). Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data. Life Sci, 60:1129-1136.
4. Brynne N, Dalén P, Alván G, Bertilsson L, Gabrielsson J. (1998). Infuence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine. Clin Pharmacol Ter, 63:529-539.
5. Postlind H, Danielson A, Lindgren A, Andersson SH. (1998). Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Drug Metab Dispos, 26:289-293.
6. Zhao L, Li Y, Fang L, He Z, Liu X, Wang L et al.(2009). Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation. Int J Pharm, 374:73-81.
7. Tan HS, Pfster WR. (1999). Pressure-sensitive adhesives for transdermal drug delivery systems. Pharm Sci Technol Today, 2:60-69.
8. Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y. (2002). The enhancing efect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull, 25:1339-1344.
9. Qi X, Liu RR, Sun D, Ackermann C, Hou H. (2003). Convolution method to predict drug concentration profles of 2,3,5,6-tetramethylpyrazine following transdermal application. Int J Pharm, 259:39-45.
10. Toddywala RD, Ulman K, Walters P, Chien YW. (1991). Efect of physicochemical properties of adhesive on the release, skin permeation and adhesiveness of adhesive-type transdermal drug delivery systems (a-TDD) containing silicone-based pressure-sensitive adhesives. Int J Pharm, 76:77-89.
11. Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF. (2006). Transdermal drug delivery system (TDDS) adhesion as a critical safety, efcacy and quality attribute. Eur J Pharm Biopharm, 64:1-8.
12. Ho KY, Dodou K. (2007). Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance. Int J Pharm, 333:24-33.
13. Inoue K, Ogawa K, Okada J, Sugibayashi K. (2005). Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J Control Release, 108:306-318.
14. Zhao X, Liu JP, Zhang X, Li Y. (2006). Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm, 327:58-64.
15. Karande P, Mitragotri S. (2009). Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta, 1788:2362-2373.
16. López A, Llinares F, Cortell C, Herráez M. (2000). Comparative enhancer efects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with diferent lipophilicities. Int J Pharm, 202:133-140.
17. Panchagnula R, Desu H, Jain A, Khandavilli S. (2005). Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: Role of solubility, partitioning and lipid bilayer perturbation. Farmaco, 60:894-899.
18. Leichtnam ML, Rolland H, Wüthrich P, Guy RH. (2006). Identifcation of penetration enhancers for testosterone transdermal delivery from spray formulations. J Control Release, 113:57-62.
19. Kokubo T, Sugibayashi K, Morimoto Y. (1991) Difusion of drug in acrylic-type pressure-sensitive adhesive matrices. Infuence of physical property of the matrices on the drug difusion. J Control Release, 17:69-78.
20. Karande P, Jain A, Mitragotri S. (2006). Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release, 115:85-93.